NIEASHA RICHARDSON: Open Payments
NPI 1053544536 · FISHERS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$982 in 57 payments from 20 companies in 2025. Trend: 2023 $809 · 2024 $1,694 · 2025 $982
Food & beverage: $982
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $270 |
| Astellas Pharma US Inc | 6 | $129 |
| ABBVIE INC. | 5 | $86 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $53 |
| Lilly USA, LLC | 3 | $51 |
| Exact Sciences Corporation | 3 | $51 |
| Collegium Pharmaceutical, Inc. | 2 | $39 |
| PFIZER INC. | 2 | $38 |
| Abbott Laboratories | 2 | $37 |
| GlaxoSmithKline, LLC. | 2 | $36 |
Products named: Veozah, Wegovy, Ozempic, XIFAXAN, MOUNJARO, VRAYLAR, Jornay PM, FREESTYLE LIBRE 3.
Industry payments across IN — which companies pay providers there.
